Enanta Pharmaceuticals (ENTA) Accumulated Depreciation & Amortization: 2012-2025
Historic Accumulated Depreciation & Amortization for Enanta Pharmaceuticals (ENTA) over the last 2 years, with Sep 2025 value amounting to $23.8 million.
- Enanta Pharmaceuticals' Accumulated Depreciation & Amortization fell 4.96% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.8 million, marking a year-over-year decrease of 8.43%. This contributed to the annual value of $23.8 million for FY2025, which is 4.96% down from last year.
- Enanta Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $23.8 million in Q3 2025, which was up 5.70% from $22.5 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $25.2 million in Q2 2024 and a low of $18.9 million during Q3 2021.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $23.7 million (2023), whereas its average is $23.1 million.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Accumulated Depreciation & Amortization rose by 20.75% in 2021, and later fell by 10.67% in 2025.
- Over the past 5 years, Enanta Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $18.9 million in 2021, then increased by 15.49% to $21.9 million in 2022, then increased by 8.63% to $23.7 million in 2023, then rose by 5.48% to $20.1 million in 2024, then dropped by 4.96% to $23.8 million in 2025.
- Its last three reported values are $23.8 million in Q3 2025, $22.5 million for Q2 2025, and $21.3 million during Q1 2025.